ColdZyme featured in the US morning show "The Balancing Act"

The American TV morning show "The Balancing Act" today featured an interview with Enzymatica CEO Claus Egstrand and Professor Glen Davison from University of Kent, who presented the first results from his ongoing study on ColdZYme and endurance athletes. Already the first results from the study show ColdZyme significantly lowers viral load and symptoms of sore throat. 

Accoording to The Balancing Act, Enzymatica has "made a genuine technological breakthrough that helps protect against airborne upper-respiratory viruses and the they cause". 

Watch the interview on YouTubeWatch the interview on Facebook